Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can home visits and texts tame Nepal's chronic disease crisis?

NCT ID NCT06740708

Disease control Sponsor: Johns Hopkins Bloomberg School of Public Health Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether home visits by female community health volunteers plus regular SMS messages can help adults in Pokhara, Nepal, better control high blood pressure, type 2 diabetes, and smoking. About 2100 participants are split into two groups: one gets the home visits and texts, the other gets usual care. The goal is to see if these simple, low-cost tools can lower blood pressure, blood sugar, and boost smoking quit rates.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
behavioral intervention: home visits by female community health volunteers and SMS messages
What this could lead to
If successful, this could provide a low-cost, scalable model for managing hypertension, diabetes, and smoking in community settings.
What could go wrong
This is a single-city study in Nepal, so results may not apply elsewhere. The intervention is behavioral, so effects may be modest and hard to sustain long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

2,100 people

The number who actually took part.

Started

Apr 2025

Expected to finish

Feb 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Meeting at least one of the following three conditions * Hypertensive, defined as * BP≥140/90 mmHg at two separate measurements * Type 2 diabetes, defined as * Fingerprick glucose≥100 mg/dL, and plasma fasting glucose ≥126 mg/dL, and HbA1c≥6.5 * Current smoker, defined as * Ever smoked ≥100 cigarettes in lifetime, and * Currently smokes every day. 2. Registered on the voter list in Pokhara. 3. Not planning to migrate outside of Pokhara during the study period Exclusion Criteria: 1. Blood pressure ≥180/120 mmHg or 2. Blood glucose \>250 mg/dL or \<54 mg/dL 3. Diagnosed with secondary hypertension by health professionals 4. Diagnosed with other diabetes besides type 2 by health professionals 5. Presenting with acute symptoms that may require hospitalizations, which includes but not limited to: * Nausea, vomiting, diarrhea * Abdominal pain * Polyuria, polydipsia, polyphagia * Loss of motor or sensory function * Altered mental status. * Chest pain, chest tightness * Dyspnea, shortness of breath * Fever 6. Diagnosed as terminally ill by a health professional, defined as life expectancy of 6 months or less. 7. Pregnant or intend to be pregnant

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hypertension are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hypertensive disorder Tobacco Smoking type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hypertension Tobacco smoking Type 2 diabetes mellitus (T2DM)

Contacts and locations

Locations

  • Pokhara Metropolitan City

    Pokhara, Gandaki, Nepal

More trials for these conditions

Other studies related to the condition(s) this trial covers.